|
|||
|
|||
Breaking News for Economic Issues in U.S. Healthcare
Third Rock pushes Rhythm venture round to $40M
Wed, Sep 08 2010
Third
Rock is jumping on board the venture bandwagon backing the Boston-based
start-up Rhythm, pushing its Series A to $40 million to fuel new trial
Read more...
Premium-hike announcements draw mixed reaction
Wed, Sep 08 2010
Both
sides of the health reform debate reacted Wednesday to the news that
health plans were blaming the new law for premium increases in the
Read more...
The Nation: No More Rahm In The White House?
Wed, Sep 08 2010
Ari Berman is a contributing writer for The Nation magazine and an Investigative Journalism Fellow at The Nation. He is the author of the forthcoming
Read more...
InoLife Technologies, Inc. Announces Immediate Availability of the Cytochrome P450 2C1 Plavix Metabolizing Test to the Medical Industry
Wed, Sep 08 2010
InoLife Technologies, Inc.
/quotes/comstock/11k!inol
(INOL0.08,
+0.04,
+80.00%)
, a service based
healthcare products development, integration and marketing Company,
is extremely pleased that their recently presented
Read more...
Defensive medicine less costly than anticipated
Wed, Sep 08 2010
For
the past several years, policymakers have linked physicians' fear of
malpractice suits to the rise in defensive medicine, and assumed these
forces were contributing
Read more...
Covidien launches opioid patient safety alliance
Wed, Sep 08 2010
Covidien
launched a patient safety organization – the Collaborating & Acting
Responsibly to Ensure Safety (CARES) Alliance – today, featuring tools
and resources for patients,
Read more...
BMS forges $885M deal to buy ZymoGenetics
Wed, Sep 08 2010
Bristol-Myers
Squibb has struck a deal to buy Seattle-based ZymoGenetics for $885
million, snaring its development partner on a mid-stage hepatitis C
program along with
Read more...
Merck's Remicade face-off puts $2.7B at risk
Wed, Sep 08 2010
The
showdown over Remicade approaches. Johnson & Johnson and Merck will
tussle over rights to the blockbuster anti-inflammatory drug--and its
successor Simponi--in arbitration later this
Read more...
St. Jude Pays $60M for 19% Stake in Med Device Co.
Wed, Sep 08 2010
St. Jude Medical, Inc., said Tuesday that it plans to pay $60 million
for a 19 percent ownership stake in CardioMEMS, Inc., an Atlanta-based
medical
Read more...
Malpractice Adds Less than 3 Percent to Healthcare Tab
Tue, Sep 07 2010
Costs associated with medical malpractice added about $55.6 billion
to the nation's total healthcare costs in 2008 -- roughly 2.4% of a
more than $2.3-trillion
Read more...
In New Health Affairs Issue: Medical Liablity Costs And ER Use
Tue, Sep 07 2010
Medical malpractice and reform proposals have been a longstanding
battleground of U.S. health policy. On the one hand, studies have shown
that health care is
Read more...
Back from Labor Day: Three Posts You Should Read
Tue, Sep 07 2010
Was there a summer slowdown this year in the tech-business world? I’m
not so sure (and neither are some other observers). In any case, let’s
Read more...
Cockroaches linked to fighting superbugs
Tue, Sep 07 2010
Cockroaches have long been regarded as an unwanted pest but in
fact they could hold the secret to treating the most resilient of
superbugs, scientists
Read more...
Ghostwritten articles overstate benefits of hormone replacement therapy and downplay harms
Tue, Sep 07 2010
"The first academic analysis of the 1500 documents unsealed in recent
litigation against the pharmaceutical giant Wyeth (now part of Pfizer)
reveals unprecedented insights into
Read more...
Steep rate hikes on way for individual health insurance
Mon, Sep 06 2010
Read more...
High-tech sector puts brakes on hiring
Mon, Sep 06 2010
For years the technology sector has been considered the most dynamic, promising and globally envied industry in the United States. It escaped the recession relatively
Read more...
City’s Efforts Fail to Dent Child Obesity
Sat, Sep 04 2010
New York City schoolchildren are as heavy, or perhaps even heavier, than the national average, despite the Bloomberg administration’s dogged efforts to improve the health
Read more...
Half Of Americans Are Taking Prescription Meds
Fri, Sep 03 2010
More than 48 percent of all Americans took at least one prescription
drug each month in 2008, which amounts to a 10 percent increase over
Read more...
Mobile Health: New Cell Phone-Based Technologies Transform Emergency Care
Wed, Sep 01 2010
Mobile phone technology is rapidly changing how healthcare is delivered, even as health wonks sit around wondering how we’re going to pay for it. While
Read more...
Health reform foes request federal funds for early retirees
Wed, Sep 01 2010
About two dozen businesses associated with high-profile opposition to the healthcare reform law are taking advantage of a provision that helps pay for their
Read more...
States take hypocritical stance on health reform
Wed, Sep 01 2010
Some states are taking a two-faced approach to the healthcare overhaul law.
Seven states are suing to overturn the healthcare reform law, saying it's unconstitutional,
Read more...
Controlling Health Care Costs: U.S. Versus England
Wed, Sep 01 2010
As leaders argue about how to control the skyrocketing costs of cancer care, some say it is worthwhile to look at how other countries, such
Read more...
New Poll Shows Support Slipping Again For Healthcare Reform Law
Wed, Sep 01 2010
After bumping up in a July poll, public support for the healthcare reform law in a new poll is back to its May levels, according
Read more...
Innovators in Boston, San Diego, San Francisco, Northwest Top World Economic Forum’s List of Technology Pioneers
Wed, Sep 01 2010
The World Economic Forum—the body behind the exclusive annual gathering in Davos, Switzerland—today released its “Technology Pioneers” list for 2011. An unusually large number of
Read more...
Genzyme CEO open to sale, not at $69 a share
Wed, Sep 01 2010
In an interview with Reuters, Termeer said it was unlikely that French drugmaker Sanofi-Aventis SA (SASY.PA) would go hostile with its $18.5 billion bid and
Read more...
MedIntelliBase® Intelligence: Knowledge → Insight → Advantage
developed by the "better way to get and access market intelligence" people at medintellibase.com
Home | Contact | Login |
Abstract Alert System by MedIntelliBase
*,® - "MedIntelliBase" and "The Next Phase" are registered trademarks of The Next Phase Consultancy, Inc.
© 2010 The Next Phase Consultancy, Inc.